(VIANEWS) - Tesla (TSLA), CSX Corporation (CSX), Addus HomeCare Corporation (ADUS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Tesla (TSLA)
37.7% sales growth and 15.64% return on equity
Tesla, Inc. designs, develops, manufactures, leases, and sells electric vehicles, and energy generation and storage systems in the United States, China, Netherlands, Norway, and internationally.
Tesla's sales growth this year is anticipated to be 58.9% and 35.7% for next year.
Year-on-year quarterly revenue growth grew by 56.8%, now sitting on 46.85B for the twelve trailing months.
Volume
Today's last reported volume for Tesla is 5332880 which is 79.61% below its average volume of 26158200.
Tesla's sales growth for the next quarter is 37.7%. The company's growth estimates for the current quarter and the next is 81.6% and 102.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.64%.
Volatility
Tesla's last day, last week, and last month's current intraday variation average was 0.61%, 5.18%, and 3.61%, respectively.
Tesla's highest amplitude of average volatility was 5.68% (day), 5.55% (last week), and 5.14% (last month), respectively.
Tesla's Stock Yearly Top and Bottom Value
Tesla's stock is valued at $908.54 at 10:22 EST, way under its 52-week high of $1,243.49 and way above its 52-week low of $539.49.
Tesla's Moving Average
Tesla's worth is below its 50-day moving average of $1,006.49 and way above its 200-day moving average of $758.25.Previous days news about Tesla(TSLA)
- Tesla and these stocks are seeing the highest interest on wallstreetbets today. According to Benzinga on Wednesday, 15 December, "What Happened: Exchange-traded fund SPDR S&P 500 ETF Trust (NYSE:SPY) is seeing the highest interest on the forum with 528 mentions as at press time, followed by Tesla with 289 mentions, data from Quiver Quantitative showed.", "Electric vehicle maker Tesla Inc. (NASDAQ:TSLA) has emerged as the most-discussed stock on Reddit's r/WallStreetBets forum as of early Wednesday."
- According to Bloomberg Quint on Wednesday, 15 December, "In October, Tesla became one of just a few companies to hit the $1 trillion valuation mark. "
- According to Benzinga on Wednesday, 15 December, "Baby Floki Doge, named after Tesla Inc. (NASDAQ:TSLA) CEO Elon Musk's pet dog Floki, is a multi-chain cryptocurrency on the Binance & Ethereum Smart Chain network.", "Read Next: Elon Musk Says Tesla Will Try Out Doge Payment For Some Merchandise; Meme Currency Spikes In Reaction"
- According to Bloomberg Quint on Wednesday, 15 December, "At a virtual bar, a giant cat in a dress served me pancakes, while a medieval knight talked about the engine capacity of Tesla Inc.'s Roadster with a cactus who nodded in agreement."
- According to Benzinga on Wednesday, 15 December, "The entrepreneur said Tuesday that Tesla "will make some merch buyable with Doge & see how it goes."
2. CSX Corporation (CSX)
13% sales growth and 27.85% return on equity
CSX Corporation, together with its subsidiaries, provides rail-based freight transportation services.
CSX Corporation's sales growth this year is expected to be 14.7% and 7.7% for next year.
Year-on-year quarterly revenue growth grew by 24.3%, now sitting on 11.92B for the twelve trailing months.
Volume
Today's last reported volume for CSX Corporation is 29595700 which is 135.24% above its average volume of 12580700.
CSX Corporation's sales growth for the next quarter is 13%. The company's growth estimates for the current quarter and the next is 25% and 14.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 27.85%.
Volatility
CSX Corporation's last day, last week, and last month's current intraday variation average was 2.38%, 0.84%, and 1.33%, respectively.
CSX Corporation's highest amplitude of average volatility was 2.58% (day), 1.44% (last week), and 2.01% (last month), respectively.
CSX Corporation's Stock Yearly Top and Bottom Value
CSX Corporation's stock is valued at $35.72 at 10:22 EST, under its 52-week high of $36.45 and way higher than its 52-week low of $27.70.
CSX Corporation's Moving Average
CSX Corporation's worth is above its 50-day moving average of $33.43 and higher than its 200-day moving average of $32.80.3. Addus HomeCare Corporation (ADUS)
12.6% sales growth and 7.6% return on equity
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States.
Addus HomeCare Corporation's sales growth this year is anticipated to be 13.3% and 8.6% for next year.
Year-on-year quarterly revenue growth grew by 11.7%, now sitting on 835.85M for the twelve trailing months.
Volume
Today's last reported volume for Addus HomeCare Corporation is 278452 which is 145.01% above its average volume of 113646.
Addus HomeCare Corporation's sales growth for the next quarter is 12.6%. The company's growth estimates for the present quarter and the next is 13.4% and 27%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.6%.
Volatility
Addus HomeCare Corporation's last day, last week, and last month's current intraday variation average was 4.24%, 2.01%, and 2.70%, respectively.
Addus HomeCare Corporation's highest amplitude of average volatility was 5.69% (day), 4.72% (last week), and 4.53% (last month), respectively.
Addus HomeCare Corporation's Stock Yearly Top and Bottom Value
Addus HomeCare Corporation's stock is valued at $90.67 at 10:22 EST, way below its 52-week high of $129.01 and way higher than its 52-week low of $73.06.
Addus HomeCare Corporation's Moving Average
Addus HomeCare Corporation's value is under its 50-day moving average of $90.85 and below its 200-day moving average of $92.54.4. NeoGenomics (NEO)
12.1% sales growth and 5.42% return on equity
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia.
NeoGenomics's sales growth this year is anticipated to be 9% and 16% for next year.
Year-on-year quarterly revenue growth declined by 3.3%, now sitting on 484.59M for the twelve trailing months.
Volume
Today's last reported volume for NeoGenomics is 1058800 which is 6.36% above its average volume of 995407.
NeoGenomics's sales growth for the next quarter is 12.1%. The company's growth estimates for the ongoing quarter and the next is a negative 200% and negative -275%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.42%.
Volatility
NeoGenomics's last day, last week, and last month's current intraday variation average was 6.07%, 3.76%, and 3.74%, respectively.
NeoGenomics's highest amplitude of average volatility was 8.82% (day), 7.15% (last week), and 6.11% (last month), respectively.
NeoGenomics's Stock Yearly Top and Bottom Value
NeoGenomics's stock is valued at $30.49 at 10:22 EST, way below its 52-week high of $61.57 and higher than its 52-week low of $30.15.